Abiopharma

🔍 Argo Timothy (Executive)

Company: MID AMERICA APARTMENT COMMUNITIES INC. (MAA)

Report Date: 2026-04-01

Detailed Transactions and Holdings:

• Acquired 2,637 shares of Common Stock (Direct)
  Date: 2026-04-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 21,863.08 | transaction_form_type: 4
• Sold 298 shares of Common Stock at $122.55 per share (Direct)
  Date: 2026-04-01 | Code: F | equity_swap_involved: 0 | shares_owned_after: 21,565.08 | transaction_form_type: 4 | Footnotes: F1
• Sold 183 shares of Common Stock at $124.73 per share (Direct)
  Date: 2026-04-06 | Code: S | equity_swap_involved: 0 | shares_owned_after: 21,382.08 | transaction_form_type: 4 | Footnotes: F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-04-01 | Code: H | nature_of_ownership: Allocated shares in ESOP | shares_owned_after: 804.40
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-04-01 | Code: H | nature_of_ownership: IRA | shares_owned_after: 28.86

Footnotes:

• F1: Disposals are being withheld to cover taxes related to vesting pursuant to shares earned and issued under a prior year restricted stock plan.
• F2: Open market sale pursuant to a 10b5-1 plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Shares were sold to meet additional tax obligations related to vestings of shares of restricted stock previously earned under a prior year restricted stock plan.